RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Insulin glargine

Improve glycemic control in adult patients with diabetes mellitus, Improve glycemic control in pediatric patients with diabetes mellitus

High-alert medication

  • Insulin, subcutaneous and IV (class)

Indications

  • Improve glycemic control in adult patients with diabetes mellitus
  • Improve glycemic control in pediatric patients with diabetes mellitus

Adult dosing

  • type 2 dm initiation: dose: 0.2; unit: units/kg; route: SC; interval: once daily, or up to 10 units; weightBased: true; maxDose: 10; maxDoseAbsolute: true; labelExcerpt: The recommended starting dosage of LANTUS in patients with type 2 diabetes who are not currently treated with insulin is 0.2 units/kg or up to 10 units once daily.

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Frequent glucose monitoring and dosage adjustment may be necessary.

Contraindications

  • Hypoglycemia
  • Hypersensitivity to insulin glargine

Clinical pearls

  • Do not administer intravenously or via an insulin pump.
  • Rotate injection sites to reduce risk of lipodystrophy.
  • Monitor blood glucose more frequently when changing insulin regimens.
  • Never share pens, syringes, or needles between patients.

Source and review

  • DailyMed label (insulin glargine, Lantus Solostar), Set ID d5e07a0c-7e14-4756-9152-9fea485d654a, effective 2025-06-02. Last reviewed: 2026-11-11